Retaspimycin hydrochloride (IPI-504): a novel heat shock protein inhibitor as an anticancer agent (Q37566640)

21 August 2017

1 reference

title

Retaspimycin hydrochloride (IPI-504): a novel heat shock protein inhibitor as an anticancer agent (English)

1 reference

retaspimycin hydrochloride

21 August 2017

1 reference

ChEBI release 2020-05-28

Britt Erika Hanson

1

1 reference

PubMed ID

19642950

21 August 2017

David H Vesole

series ordinal

2

1 reference

PubMed ID

19642950

21 August 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

Expert Opinion on Investigational Drugs

21 August 2017

1 reference

21 August 2017

18

1 reference

21 August 2017

9

1 reference

21 August 2017

1375-1383

1 reference

Hsp90 inhibitors as novel cancer chemotherapeutic agents

21 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543780903158934

Hsp90: a novel target for the disruption of multiple signaling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903158934

The aggresome pathway as a target for therapy in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903158934

Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903158934

Heat shock protein and proteasome targeting agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903158934

Discovery and development of heat shock protein 90 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903158934

The Hsp90 chaperone machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903158934

Unusual expression and localization of heat-shock proteins in human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903158934

The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903158934

Heat-shock protein 90 associates with N-terminal extended peptides and is required for direct and indirect antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903158934

Hsp90alpha chaperones large C-terminally extended proteolytic intermediates in the MHC class I antigen processing pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903158934

IPI-504, a novel and soluble HSP-90 inhibitor, blocks the unfolded protein response in multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903158934

The heat shock protein 90 inhibitor IPI-504 induces apoptosis of AKT-dependent diffuse large B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903158934

Inhibition of heat shock protein 90 prolongs survival of mice with BCR-ABL-T315I-induced leukemia and suppresses leukemic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903158934

Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903158934

10.1517/13543780903158934

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19642950